Nucleus DNA
Overview
Nucleus DNA is a venture capital firm investing in early-stage companies in the technology and healthcare sectors. The firm focuses on sectors such as FinTech, SaaS, AI, data, and wellness, operating in both the United States and the European Union. Nucleus DNA has made over 100 investments, committing more than $45 million to more than 25 companies, and has consulted for over 25 companies.
Investment Focus
- Early-stage companies in technology and healthcare sectors
Get the full list of 54,000+ investors
Nucleus DNA and every other firm and angel in the database — as one spreadsheet you keep.
$19one-time payment · no subscription- All 54,000+ investors — VC firms, private equity, family offices and angels
- The key person to contact at each one, with their job title
- Their work email address
- Their phone number
- Their LinkedIn profile
- Delivered as a single .xlsx file — download it as many times as you like
Every profile on this site is one row of the file, with the contact details masked — browse a few before you buy.
Frequently asked questions about Nucleus DNA
What sectors does Nucleus DNA invest in?
Nucleus DNA invests in FinTech, SaaS, AI, Wellness and Data, and is based in New York, United States. Nucleus DNA is listed as a venture capital in the ConnectSafely investor database.
What stage does Nucleus DNA invest at?
Nucleus DNA backs companies at Pre-Seed, Seed, Early Stage, Series A, Series B and Growth.
Which regions does Nucleus DNA invest in?
Nucleus DNA invests across United States and European Union.
How do I contact Nucleus DNA?
Nucleus DNA's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of the team.
Last updated · Source: ConnectSafely investor database
